A neutralizable epitope is induced on HGF upon its interaction with its receptor cMet

Biochemical and Biophysical Research Communications

Volumn 354, Issue 1, 2007, Pages 115-121

  Kim, Kisu ^a   Hur, Youngmi ^a   Ryu, En Kyung ^a   Rhim, Jung Hyo ^a   Choi, Cha Yong ^b   Baek, Cheol Min ^c   Lee, Jae Ho ^c   Chung, Junho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Antibody; cMet; HGF; Phage display

Indexed keywords

EPITOPE; LYSYLSERYLLEUCYLSERYLARGINYLHISTIDYLASPARTYLHISTIDYLISOLEUCYLHISTIDYLHISTIDYLHISTIDINE; PEPTIDE; PEPTIDE LIBRARY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; COMBINATORIAL LIBRARY; COMPLEX FORMATION; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; MOLECULAR MIMICRY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RABBIT; SEQUENCE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPE MAPPING; EPITOPES; HEPATOCYTE GROWTH FACTOR; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-MET; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 33846289183     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.164     Document Type: Article

References (15)

1. Jiang W.G., Martin T.A., Parr C., Davies G., Matsumoto K., and Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit. Rev. Oncol. Hematol. 53 (2005) 35-69
2. Burgess T., Coxon A., Meyer S., Sun J., Rex K., Tsuruda T., Chen Q., Ho S.Y., Li L., Kaufman S., McDorman K., Cattley R.C., Sun J., Elliott G., Zhang K., Feng X., Jia X.C., Green L., Radinsky R., and Kendall R. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors. Cancer Res. 66 (2006) 1721-1729
3. Kim K.J., Wang L., Su Y.C., Gillespie G.Y., Salhotra A., Lal B., and Laterra J. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin. Cancer Res. 12 (2006) 1292-1298
4. Albanell J., Codony J., Rovira A., Mellado B., and Gascon P. Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv. Exp. Med. Biol. 532 (2003) 253-268
5. Zamarron C., Ginsberg M.H., and Plow E.F. Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb. Haemost. 64 (1990) 41-46
6. Zamarron C., Ginsberg M.H., and Plow E.F. A receptor-induced binding site in fibrinogen elicited by its interaction with platelet membrane glycoprotein IIb-IIIa. J. Biol. Chem. 266 (1991) 16193-16199
7. Boudreaux M.K., Panangala V.S., and Bourne C. A platelet activation-specific monoclonal antibody that recognizes a receptor-induced binding site on canine fibrinogen. Vet. Pathol. 33 (1996) 419-427
8. Barbas III C.F., Burton D.R., Scott J.K., and Silverman G.J. Phage Display: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
9. Im S.Y., Kim K.S., Yun C.O., Kim J.H., Yi K.S., and Chung J. Generation of a rabbit V(H) domain antibody polyspecific to c-Met and adenoviral knob protein. Biochem. Biophys. Res. Commun. 339 (2006) 305-312
10. Karlsson R., Michaelsson A., and Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods 145 (1991) 229-240
11. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
12. Chung J., Park S., Kim D., Rhim J., Kim I., Choi I., Yi K., Ryu S., Suh P., Chung D., Bae Y., Shin Y., and Park S. Identification of antigenic peptide recognized by the anti-JL1 leukemia-specific monoclonal antibody from combinatorial peptide phage display libraries. J. Cancer Res. Clin. Oncol. 128 (2002) 641-649
13. Lokker N.A., Mark M.R., Luis E.A., Bennett G.L., Robbins K.A., Baker J.B., and Godowski P.J. Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11 (1992) 2503-2510
14. Kirchhofer D., Yao X., Peek M., Eigenbrot C., Lipari M.T., Billeci K.L., Maun H.R., Moran P., Santell L., Wiesmann C., and Lazarus R.A. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling. J. Biol. Chem. 279 (2004) 39915-39924
15. Frelinger III A.L., Du X.P., Plow E.F., and Ginsberg M.H. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J. Biol. Chem. 266 (1991) 17106-17111